|
1
|
Ikeda M, Shima K, Kondo T and Semba I:
Atypical immunohistochemical patterns can complement the
histopathological diagnosis of oral premalignant lesions. J Oral
Biosci. 62:93–98. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Speight PM and Farthing PM: The pathology
of oral cancer. Br Dent J. 225:841–847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brouns E, Baart J, Karagozoglu Kh, Aartman
I, Bloemena E and van der Waal I: Malignant transformation of oral
leukoplakia in a well-defined cohort of 144 patients. Oral Dis.
20:e19–e24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sato F, Bhawal UK, Tojyo I, Fujita S,
Murata SI and Muragaki Y: Differential expression of claudin-4,
occludin, SOX2 and proliferating cell nuclear antigen between
basaloid squamous cell carcinoma and squamous cell carcinoma. Mol
Med Rep. 20:1977–1985. 2019.PubMed/NCBI
|
|
5
|
Odell E, Kujan O, Warnakulasuriya S and
Sloan P: Oral epithelial dysplasia: Recognition, grading and
clinical significance. Oral Dis. 27:947–976. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nobusawa A, Sano T, Negishi A, Yokoo S and
Oyama T: Immunohistochemical staining patterns of cytokeratins 13,
14, and 17 in oral epithelial dysplasia including orthokeratotic
dysplasia. Pathol Int. 64:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fish KJ, Cegielska A, Getman ME, Landes GM
and Virshup DM: Isolation and characterization of human casein
kinase I epsilon (CKI), a novel member of the CKI gene family. J
Biol Chem. 270:14875–14883. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee C, Etchegaray JP, Cagampang FR, Loudon
AS and Reppert SM: Posttranslational mechanisms regulate the
mammalian circadian clock. Cell. 107:855–867. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Zhou L, Wang Y, Peng Q, Li H,
Zhang X, Su Z, Song J, Sun Q, Sayed S, et al: The CK1δ/ε-AES axis
regulates tumorigenesis and metastasis in colorectal cancer.
Theranostics. 11:4421–4435. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodriguez N, Yang J, Hasselblatt K, Liu S,
Zhou Y, Rauh-Hain JA, Ng SK, Choi PW, Fong WP, Agar NY, et al:
Casein kinase I epsilon interacts with mitochondrial proteins for
the growth and survival of human ovarian cancer cells. EMBO Mol
Med. 4:952–963. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Sato F, Tanimoto K, Rajeshwaran N,
Thangavelu L, Makishima M and Bhawal UK: The potential roles of
Dec1 and Dec2 in Periodontal inflammation. Int J Mol Sci.
22:103492021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sato F, Bhawal UK, Sugiyama N, Osaki S,
Oikawa K and Muragaki Y: Potential role of DEC1 in cervical cancer
cells involving overexpression and apoptosis. Clocks Sleep.
2:26–38. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhawal UK, Sato F, Arakawa Y, Fujimoto K,
Kawamoto T, Tanimoto K, Ito Y, Sasahira T, Sakurai T, Kobayashi M,
et al: Basic helix-loop-helix transcription factor DEC1 negatively
regulates cyclin D1. J Pathol. 224:420–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato F, Bhawal UK, Yoshimura T and
Muragaki Y: DEC1 and DEC2 crosstalk between circadian rhythm and
tumor progression. J Cancer. 7:153–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Sato F, Yamada T, Bhawal UK,
Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada
K, et al: The BHLH transcription factor DEC1 plays an important
role in the epithelial-mesenchymal transition of pancreatic cancer.
Int J Oncol. 41:1337–1346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Honma S, Kawamoto T, Takagi Y, Fujimoto K,
Sato F, Noshiro M, Kato Y and Honma K: Dec1 and Dec2 are regulators
of the mammalian molecular clock. Nature. 419:841–844. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai ST and Jin YT: Proliferating cell
nuclear antigen (PCNA) expression in oral squamous cell carcinomas.
J Oral Pathol Med. 24:313–315. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu SS and Cirillo N: The molecular markers
of cancer stem cells in head and neck tumors. J Cell Physiol.
235:65–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bourguignon LYW, Earle C and Shiina M:
Activation of matrix hyaluronan-mediated CD44 signaling, epigenetic
regulation and chemoresistance in head and neck cancer stem cells.
Int J Mol Sci. 18:18492017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghazi N, Saghravanian N, Taghi Shakeri M
and Jamali M: Evaluation of CD44 and TGF-B expression in oral
carcinogenesis. J Dent (Shiraz). 22:33–40. 2021.PubMed/NCBI
|
|
21
|
Sato F, Otsuka T, Kohsaka A, Le HT, Bhawal
UK and Muragaki Y: Smad3 suppresses epithelial cell migration and
proliferation via the clock gene Dec1, which negatively regulates
the expression of clock genes Dec2 and Per1. Am J Pathol.
189:773–783. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato F, Muragaki Y and Zhang Y: DEC1
negatively regulates AMPK activity via LKB1. Biochem Biophys Res
Commun. 467:711–716. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ooshima A, Park J and Kim SJ:
Phosphorylation status at Smad3 linker region modulates
transforming growth factor-β-induced epithelial-mesenchymal
transition and cancer progression. Cancer Sci. 110:481–488. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roberts AB, Tian F, Byfield SD, Stuelten
C, Ooshima A, Saika S and Flanders KC: Smad3 is key to
TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,
tumor suppression and metastasis. Cytokine Growth Factor Rev.
17:19–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kon N, Hirota T, Kawamoto T, Kato Y,
Tsubota T and Fukada Y: Activation of TGF-beta/activin signalling
resets the circadian clock through rapid induction of Dec1
transcripts. Nat Cell Biol. 10:1463–1469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ehata S, Hanyu A, Hayashi M, Aburatani H,
Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T and Miyazono K:
Transforming growth factor-beta promotes survival of mammary
carcinoma cells through induction of antiapoptotic transcription
factor DEC1. Cancer Res. 67:9694–9703. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zawel L, Yu J, Torrance CJ, Markowitz S,
Kinzler KW, Vogelstein B and Zhou S: DEC1 is a downstream target of
TGF-beta with sequence-specific transcriptional repressor
activities. Proc Natl Acad Sci USA. 99:2848–2853. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo Q, Yang C and Gao F: The state of CD44
activation in cancer progression and therapeutic targeting. FEBS J.
Sep 3–2021.(Epub ahead of print). View Article : Google Scholar
|
|
29
|
Xiang R, Cui Y, Wang Y, Xie T, Yang X,
Wang Z, Li J and Li Q: Circadian clock gene Per2 downregulation in
non-small cell lung cancer is associated with tumour progression
and metastasis. Oncol Rep. 40:3040–3048. 2018.PubMed/NCBI
|
|
30
|
Lin SH, Lin YM, Yeh CM, Chen CJ, Chen MW,
Hung HF, Yeh KT and Yang SF: Casein kinase 1 epsilon expression
predicts poorer prognosis in low T-stage oral cancer patients. Int
J Mol Sci. 15:2876–2891. 2014. View Article : Google Scholar : PubMed/NCBI
|
